Anton W. Langerak

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 200 publications

Challenges and future directions of AIRR-seq-based diagnostics.

Challenges and future directions of AIRR-seq-based diagnostics.

Journal: Immunoinformatics (Amsterdam, Netherlands)
Published: May 25, 2026

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies.

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies.

Journal: Blood cancer journal
Published: April 20, 2026

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Journal: The Lancet. Haematology
Published: January 08, 2026

ABO: A 3D stroma-supported culture platform enabling full human B-lymphopoiesis for disease modeling and gene therapy development.

ABO: A 3D stroma-supported culture platform enabling full human B-lymphopoiesis for disease modeling and gene therapy development.

Journal: Cell reports. Medicine
Published: November 03, 2025

Next-generation sequencing-based IG clonality analysis to discriminate reactive infiltrates from minimal lymphoma involvement in paired lymphoma and bone marrow biopsies; a EuroClonality-NGS Working Group study.

Next-generation sequencing-based IG clonality analysis to discriminate reactive infiltrates from minimal lymphoma involvement in paired lymphoma and bone marrow biopsies; a EuroClonality-NGS Working Group study.

Journal: Histopathology
Published: September 25, 2025

Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.

Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.

Journal: Research square
Published: September 02, 2025

Chronic lymphocytic leukemia specificity analyses unveil bacterial lipopolysaccharides as the cognate ligands of established stereotyped BCR subsets.

Chronic lymphocytic leukemia specificity analyses unveil bacterial lipopolysaccharides as the cognate ligands of established stereotyped BCR subsets.

Journal: Blood cancer journal
Published: August 27, 2025

Pubertal stage specific changes in T-cell subpopulations in healthy individuals.

Pubertal stage specific changes in T-cell subpopulations in healthy individuals.

Journal: Scientific reports
Published: July 30, 2025

Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemia.

Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemia.

Journal: Signal transduction and targeted therapy
Published: July 12, 2025

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Journal: Blood
Published: June 25, 2025

Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes.

Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes.

Journal: Nature communications
Published: June 05, 2025

RAG1 lentiviral gene therapy restores T-cell development of RAG1-SCID patient cells in artificial thymic organoids.

RAG1 lentiviral gene therapy restores T-cell development of RAG1-SCID patient cells in artificial thymic organoids.

Journal: Blood advances
Published: April 25, 2025
Showing 1-12 of 200

Last Updated: 09/26/2026